Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Hemorrhagic complications after systemic thrombolysis in acute stroke patients with abnormal baseline coagulation.

Brunner F, Tomandl B, Schröter A, Mellinghoff C, Haldenwanger A, Hildebrandt H, Kastrup A.

Eur J Neurol. 2011 Dec;18(12):1407-11. doi: 10.1111/j.1468-1331.2011.03455.x. Epub 2011 Jun 14.

PMID:
21672089
2.

Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.

Matute MC, Masjuan J, Egido JA, Fuentes B, Simal P, Díaz-Otero F, Reig G, Díez-Tejedor E, Gil-Nuñez A, Vivancos J, Alonso de Leciñana M.

Cerebrovasc Dis. 2012;33(3):231-9. doi: 10.1159/000334662. Epub 2012 Jan 19.

PMID:
22261670
3.

Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.

Seet RC, Rabinstein AA.

Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Review.

4.

Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.

Cocho D, Borrell M, Martí-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvís R, Díaz-Manera JA, Martínez-Domeño A, Martínez-Lage M, Millán M, Fontcuberta J, Martí-Vilalta JL.

Stroke. 2006 Apr;37(4):996-9. Epub 2006 Feb 23.

5.

Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?

Hermann A, Dzialowski I, Koch R, Gahn G.

J Neurol Sci. 2009 Sep 15;284(1-2):155-7. doi: 10.1016/j.jns.2009.05.003. Epub 2009 May 26.

PMID:
19473668
6.

Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.

Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, Nolte CH.

Stroke. 2013 Nov;44(11):3217-9. doi: 10.1161/STROKEAHA.113.002859. Epub 2013 Sep 3.

7.

Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.

Dorado L, Millán M, de la Ossa NP, Guerrero C, Gomis M, López-Cancio E, Ricciardi AC, Dávalos A.

Eur J Neurol. 2010 Feb;17(2):301-6. doi: 10.1111/j.1468-1331.2009.02843.x. Epub 2009 Nov 12.

PMID:
19912320
8.

Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.

Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabín J.

Stroke. 2004 Sep;35(9):2123-7. Epub 2004 Jul 8.

9.

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.

Lansberg MG, Albers GW, Wijman CA.

Cerebrovasc Dis. 2007;24(1):1-10. Epub 2007 May 22. Review.

10.

Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.

Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1235-43. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.026. Epub 2015 Apr 16.

PMID:
25891755
11.

Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.

Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP, Wahlgren N; Scientific Committee of SITS International.

Stroke. 2014 Jun;45(6):1657-63. doi: 10.1161/STROKEAHA.114.004923. Epub 2014 May 1.

12.

Elevated international normalized ratio as a manifestation of post-thrombolytic coagulopathy in acute ischemic stroke.

Lee VH, Conners JJ, Cutting S, Song SY, Bernstein RA, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2139-2144. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.021. Epub 2014 Jul 28.

PMID:
25081309
13.

Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.

Seet RC, Zhang Y, Moore SA, Wijdicks EF, Rabinstein AA.

Stroke. 2011 Aug;42(8):2333-5. doi: 10.1161/STROKEAHA.111.614214. Epub 2011 Jun 9.

14.

Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?

Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ.

Int J Stroke. 2016 Oct;11(7):783-90. doi: 10.1177/1747493016654289. Epub 2016 Jun 16.

PMID:
27312681
15.

Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.

Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.

Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1.

PMID:
22854333
16.

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial.

Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, Molinari GF, Frederick LS, Roberts HC, Gebel JM, Sila CA, Schulz GA, Roberts RS, Gent M.

Neurology. 2001 Nov 13;57(9):1603-10.

PMID:
11706099
17.

Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy?

Hsieh CY, Lin HJ, Sung SF, Hsieh HC, Lai EC, Chen CH.

Cerebrovasc Dis. 2014;37(1):51-6. doi: 10.1159/000356348. Epub 2013 Dec 21.

PMID:
24401854
18.

The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.

Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.

Cerebrovasc Dis. 2007;24(1):56-65. Epub 2007 May 22.

PMID:
17519545
19.

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.

Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ; CLEAR Trial Investigators.

Stroke. 2008 Dec;39(12):3268-76. doi: 10.1161/STROKEAHA.108.517656. Epub 2008 Sep 4.

20.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092

Supplemental Content

Support Center